Kyle Musgrove is a patent trial and appellate lawyer who primarily focuses on the life sciences industry. He has particular experience helping pharmaceutical companies navigate patent litigation and bring their products to market, including through Abbreviated New Drug Applications (ANDA) and 505(b)(2) applications. He also provides general intellectual property counsel and litigates cases related to many different technology areas, including chemical processing, nutritional supplements, biosimilars, biologics, and medical devices. He represents a range of international and American companies.
Kyle has 25 years of experience in intellectual property litigation and has a strong track record of invalidating patents or clearing companies of infringement allegations, including multiple cases involving brand products with sales exceeding $1 billion per year. Additionally, Kyle has practiced before the United States International Trade Commission and litigated antitrust violations relating to allegations of “sham” litigation brought by patentees.
For each client and each engagement, Kyle makes the investment necessary to understand that client's business and craft a strategy that prioritizes how that client defines success. This approach has often facilitated favorable settlements for his clients while avoiding the uncertainty and expense of protracted litigation. He has also helped clients avoid disputes in the first place by assessing potential patent infringement or invalidity issues and, where appropriate, negotiating intellectual property agreements.